Skip to content

News Category: Health & Medical

EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement

By asianet

EditForce, Inc. (Headquarters: Fukuoka, President and CEO: Takashi Ono; hereinafter “EditForce”) has entered into a License Agreement (hereinafter “Agreement”) with Mitsubishi Tanabe Pharma Corporation (Headquarters: Osaka, Representative Director: Hiroaki Ueno; hereinafter “MTPC”) to research, develop and commercialize potential gene therapy products for a specific target disease in the field of CNS by utilizing EditForce’s proprietary … Continued

Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders

By asianet

– Octapharma to present new clinical and scientific data from across Octapharma’s haematology and critical care portfolios during the ISTH 2022 Congress – Data to be presented in 11 poster presentations and during two Supported Symposia – New data from the extensive clinical trial programme with Nuwiq(R) (simoctocog alfa) to be presented, confirming Nuwiq(R)’s efficacy … Continued

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms

By asianet

– Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire(R) – 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment – 87.8% said they would recommend treatment to others with tinnitus Neuromod Devices Limited, the Irish medical device company specialising in the … Continued

Tarkus, the Colombian phyto-therapeutic laboratory that is conquering the world with its medical cannabis products

By asianet

— Tarkus Pharma Lab, the first pharmaceutical laboratory located in a Free Trade Zone in Colombia, has become a global industry benchmark, developing raw materials and final products derived from medical cannabis with the highest quality, and exporting to various regions of the world. — The National Institute for Drug and Food Surveillance (Instituto Nacional … Continued

NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe

By asianet

– Combines NewAmsterdam’s lead clinical program obicetrapib with Menarini’s deep cardiovascular disease and regional expertise – Total deal value of over 1 billion euros; including 142.5 million euros upfront payment and committed R&D funding plus potential milestones and double-digit royalties on net product sales in Europe – Obicetrapib is a next-generation oral, low-dose and once-daily … Continued

Amai Proteins, producer of 100% protein sweetener that reduces sugar in Food & Beverages by up to 70%, voted Global Winner at the 2022 Extreme Tech Challenge Competition

By asianet

Amai Proteins , an Israeli start-up developer of novel designer proteins that answer the needs of consumers and industry, is the Global Winner of the 2022 XTC competition. Extreme Tech Challenge (XTC) is the world’s largest start-up competition for purpose-driven companies. Over 2000+ start-ups from 100+ countries competed in 10 impact areas ranging from Biotech … Continued

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

By asianet

Summary The Institute of Functional Neuroscience, a world leading treatment and rehabilitation centre utilising the latest technologies in neuroplasticity research, and MetaCell, an innovative life science software company specialised in cutting-edge research software for major pharma, biotech, and academic institutions, have partnered to launch IFN Neurologic ( https://ifnneurologic.com/ ). This application will help clinicians to … Continued

Abcam: Appointment of Vice President of Investor Relations

By asianet

Abcam [https://corporate.abcam.com/] plc (“Abcam,” “Company,” “Group”) (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations. Tommy, who will be based in our Waltham, MA office, has over 20 years’ experience in the life sciences sector, largely focused … Continued